Valuation: Pharmaids Pharmaceuticals Limited

Market Cap 1.07B 11.19M 9.64M 9.13M 8.27M 15.52M 15.6M 108M 41.69M 544M 42.02M 41.1M 1.72B P/E 2025
-22.5x
P/E 2026 -8.33x
Enterprise Value 1.33B 13.95M 12.02M 11.38M 10.32M 19.36M 19.45M 135M 51.99M 678M 52.4M 51.25M 2.14B EV / Sales 2025
14.5x
EV / Sales 2026 4.45x
Free-Float
25.69%
Yield 2025 *
-
Yield 2026 -
13/08 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
30/05 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
13/02 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
05/01 Pharmaids Pharmaceuticals Limited Announces Completion of Term of Mopperthy Sudheer as Independent Director and Member of the Audit Committee and Nomination & Remuneration Committee, Effective January 5, 2026 CI
02/01 Pharmaids Pharmaceuticals Limited Appoints Dr. Yogananda Moolemath as Independent Director, Effective January 1, 2026 CI
29/11 Pharmaids Pharmaceuticals appoints P N Vijay as chairman effective December 5, 2025 RE
28/11 Pharmaids Pharmaceuticals Limited Announces Board and Committee Changes CI
12/11 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
18/09/25 Sourabh Hadimani completed the acquisition of 66.50% stake in Anugraha Chemicals P. Ltd. from Pharmaids Pharmaceuticals Limited. CI
18/08/25 Shankarappa Nagaraja Vinaya Babu completed the acquisition of 7.68% stake in Pharmaids Pharmaceuticals Limited for approximately INR 170 million. CI
07/08/25 Pharmaids Pharmaceuticals Limited Announces Executive Changes, Effective August 7, 2025 CI
07/08/25 Pharmaids Pharmaceuticals Limited Announces Resignation of S Prasad as the Chief Executive Officer Effective August 07, 2025 CI
07/08/25 Pharmaids Pharmaceuticals CEO S Prasad resigns RE
1 day+0.73%
1 week-2.51%
Current month-4.66%
1 month-10.83%
3 months+4.66%
6 months-10.14%
Current year-36.40%
1 week 29.5
Extreme 29.5
31.7
1 month 29.2
Extreme 29.2
34.79
Current year 25.6
Extreme 25.6
50.9
1 year 25.6
Extreme 25.6
66
3 years 25.6
Extreme 25.6
87.46
5 years 10.17
Extreme 10.17
87.46
10 years 2.15
Extreme 2.15
87.46
Manager TitleAgeSince
Director of Finance/CFO - 13/10/2022
Chief Tech/Sci/R&D Officer - 07/08/2025
Compliance Officer - 14/08/2024
Director TitleAgeSince
Director/Board Member - 09/07/2022
Director/Board Member - -
Chairman 75 05/12/2025
Change 5-day change 1-year change 3-year change Capi.($)
+0.73%-2.51%-47.52%-17.75% 11.19M
-0.65%-2.93%+47.70%+86.30% 994B
-0.29%-3.51%+49.15%+61.95% 640B
+0.83%+0.26%+17.76%+70.10% 454B
+4.50%+1.22%+37.44%+37.89% 337B
+2.62%-8.69%+17.30%+25.57% 261B
+2.46%-0.48%+4.99%+10.82% 246B
-1.34%-13.70%+36.53%+46.70% 204B
+1.67%-6.09%-20.94%-58.89% 190B
-0.75%-4.82%+25.46%+85.90% 178B
Average +1.10%-5.43%+16.79%+34.86% 350.48B
Weighted average by Cap. +0.98%-4.42%+32.34%+55.09%

Financials

2025 2026
Net sales 194M 2.04M 1.75M 1.66M 1.51M 2.82M 2.84M 19.72M 7.58M 98.94M 7.64M 7.48M 313M 279M 2.92M 2.51M 2.38M 2.16M 4.05M 4.07M 28.28M 10.87M 142M 10.96M 10.72M 448M
Net income -108M -1.13M -972K -920K -834K -1.56M -1.57M -10.93M -4.2M -54.83M -4.24M -4.14M -173M -117M -1.23M -1.06M -1M -907K -1.7M -1.71M -11.88M -4.57M -59.61M -4.61M -4.5M -188M
Net Debt 399M 4.17M 3.6M 3.41M 3.09M 5.79M 5.82M 40.45M 15.55M 203M 15.68M 15.33M 641M 264M 2.76M 2.38M 2.25M 2.04M 3.83M 3.85M 26.78M 10.3M 134M 10.38M 10.15M 424M
Logo Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.
Employees
127
Date Price Change Volume
11/09/26 INR 30.31 +0.73% 774
10/09/26 INR 30.09 -0.40% 10,648
09/09/26 INR 30.21 +0.23% 4,297
08/09/26 INR 30.14 -0.56% 12,512
07/09/26 INR 30.31 -2.51% 13,277
  1. Stock Market
  2. Stocks
  3. PHARMAID Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!